https://www.cancer.gov/news-events/press-releases/2018/immun...
https://clinicaltrials.gov/ct2/show/NCT01174121
https://www.forbes.com/sites/victoriaforster/2018/06/04/new-...
https://www.cbsnews.com/news/immunotherapy-treatment-saves-l...
https://www.cancer.gov/news-events/press-releases/2018/immun...
https://clinicaltrials.gov/ct2/show/NCT01174121
https://www.forbes.com/sites/victoriaforster/2018/06/04/new-...
https://www.cbsnews.com/news/immunotherapy-treatment-saves-l...
[1] https://www.fda.gov/NewsEvents/PublicHealthFocus/ExpandedAcc...
With sufficient guidance and information, when available, I'm simply saying that informed patients may opt for highly speculative treatment options, on a case-by-case basis.
I can't speak to your question directly, will check it out...
Fundamentally the FDA is very against right to try because they believe, correctly, that it reduces the incentive for patients to participate in medical trials - why risk being in the control group if you don't have to? My (perhaps flawed) understanding is that the FDA doesn't not approve Compassionate Use very often for this reason, although they probably use safety as the official excuse.
There are also ethics guidelines that deal with control group selection. If an effective approved drug exists, usually that has to be the control arm, not a placebo. So a patient will get a drug that works in the control arm, though maybe not in the active arm
The context for "right to try" is a person with a terminal condition that does not respond to any conventional therapies. In essence, the choice is between experimental treatments and hospice.
> If an effective approved drug exists, usually that has to be the control arm, not a placebo.
There will always be a placebo in a stage 3 trial.
FDA guidelines are you need "at least two adequate and well-controlled studies, each convincing on its own, to establish effectiveness" [1]. Well controlled can be placebo controlled or active control
[0]: https://www.prnewswire.com/news-releases/upadacitinib-monoth...
[1]: https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegula...